F255-0235 Screening compound: N-{4-[2-(1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-3-(2,3,4,9-tetrahydro-1H-carbazol-9-yl)propanamide

F255-0235 Screening compound: N-{4-[2-(1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-3-(2,3,4,9-tetrahydro-1H-carbazol-9-yl)propanamide
F255-0235 Screening compound: N-{4-[2-(1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-3-(2,3,4,9-tetrahydro-1H-carbazol-9-yl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F255-0235
N-{4-[2-(1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-3-(2,3,4,9-tetrahydro-1H-carbazol-9-yl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F255-0235

Molecular Formula

C30H30N4O (C30 H30 N4 O)

Compound Name

N-{4-[2-(1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-3-(2,3,4,9-tetrahydro-1H-carbazol-9-yl)propanamide

IUPAC name

N-{4-[2-(1H-13-benzodiazol-2-yl)ethyl]phenyl}-3-(2349-tetrahydro-1H-carbazol-9-yl)propanamide

SMILES

O=C(CCn1c(cccc2)c2c2c1CCCC2)Nc1ccc(CCc2nc(cccc3)c3[nH]2)cc1

InChI

InChI=1S/C30H30N4O/c35-30(19-20-34-27-11-5-1-7-23(27)24-8-2-6-12-28(24)34)31-22-16-13-21(14-17-22)15-18-29-32-25-9-3-4-10-26(25)33-29/h1,3-5,7,9-11,13-14,16-17H,2,6,8,12,15,18-20H2,(H,31,35)(H,32,33)

InChI Key

DQRWZLDUBMZTGK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14946141

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

462.59

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

6.399

Distribution Coefficient, logD

6.374

Water Solubility, LogSw

-6.28

Polar Surface Area

44.482

Acid Dissociation Constant (pKa)

11.93

Base Dissociation Constant (pKb)

6.18

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.70

F255-0235 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

DGK Inhibitors Library (10558 compounds)

Lipid Metabolism Library (9174 compounds)

PLpro Library (6343 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cardiovascular
  • Metabolic
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F255-0235 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F255-0235?
Check Price and Availability of F255-0235, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F255-0235 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F255-0235
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F255-0235
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F255-0235 available by request